FDA Taps Neurologists For NMT Medical’s PFO Closure Device, First To Panel
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical's PMA filing for its StarFlex implant for the closure of patent foramen ovale will be the first device to be reviewed for that indication by FDA's Circulatory System Devices Panel, the company notes
You may also be interested in...
AGA Medical Amplatzer Trial For PFO To Start By Q3, Expanding On HDE
AGA Medical plans to seek full PMA approval of its Amplatzer occluder system for patent foramen ovale (PFO) following receipt of limited approval via humanitarian device exemption, announced April 10
NMT Arbitration Ends With Sale Of Disputed Vena Cava Assets To Bard
Expanded commercialization of NMT Medical's CardioSeal cardiac septal occluder system will be funded in part by the recent sale of the firm's vena cava filter business to C.R. Bard for up to $34 mil. plus royalties.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.